Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Backers
1
Newfund
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Nov 8, 2023 Founded per the company register
Registers and programsofficial lists and records that name the company
Legal entity Soihtu DTx Oy ytj.fi
Registered 8 Nov 2023
Backed byfrom the funds' portfolios and accelerator catalogs
Similar startupsby what they do, their industry and backers
Myollie2 roles
Myollie is a healthcare technology company that develops and commercializes a suite of digital therapeutics for the treatment of chronic…
One simple step to care for your heart Introducing Bodyport We are a biomarker-guided digital therapeutics company that aims to address…
Health2SyncVenture round $20M · 18 mo ago • 51-200 employees
Health2Sync provides patients and care providers with data-driven Digital Therapeutics and personalized healthcare management services…
Nurea develops AI solution for vascular diseases to assist physicians in their decision-making process, such as EVAR surgical planning.
NeurogleeFounded 2019
Neuroglee develops digital therapeutics for people with early Alzheimer's disease and mild cognitive impairment. Its programmes combine…
Award-winning digital therapeutic programs for diabetes care and weight loss trusted by doctors. 15K+ people have prevented, managed and…

Overview

Treating depression through gameplay. We revolutionize depression treatment through engaging game-based Digital Therapeutics (DTx).

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1